5 completed. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
| Phase 2 | 1 | Completed 1 |
Follow Dust Mite Allergy: new trials by email Literature Review of Dust Mite Allergy trials Research Report on Dust Mite Allergy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM) PURETHAL Mites 50,000 AUeq/ml, Biological/Vaccine: Placebo - House Dust Mite Allergy, House Dust Mite Rhinitis | Phase 3 | Completed | HAL Allergy | 691 | 2024-09-09 | 2026-08-10 |
| Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR 300 IR, Placebo - Rhinitis, Allergic, Perennial, House Dust Mite Allergy | Phase 3 | Completed | Stallergenes Greer | 1607 | 2015-09-29 | 2019-10-14 |
| A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet AIT Tablet - House Dust Mite Allergy | Phase 3 | Completed | ALK-Abelló A/S | 992 | 2011-10-01 | 2017-01-30 |
| Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma Acaroid, Placebo - Respiratory Hypersensitivity | Phase 3 | Completed | Allergopharma GmbH & Co. KG | 130 | 2005-05-01 | 2015-01-15 |
| Fish Oil and Asthma in House Dust Mite Allergy polyunsatturated fatty acids (fish oil) - Allergic Asthma, Bronchial Inflammation | Phase 2 / Phase 3 | Completed | Johann Wolfgang Goethe University Hospital | 23 | 2004-04-01 | 2006-09-29 |
Hypersensitivity (2) · Asthma (1) · Respiratory Hypersensitivity (1) · Rhinitis (1) · Rhinitis, Allergic, Perennial (1)
Hypersensitivity, Immediate (5) · Immune System Diseases (5) · Nose Diseases (5) · Otorhinolaryngologic Diseases (5) · Respiratory Tract Diseases (5) · Rhinitis, Allergic (5) · Respiratory Hypersensitivity (4) · Rhinitis (4) · Rhinitis, Allergic, Perennial (4) · Hypersensitivity (3) · Bronchial Diseases (1) · Infections (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Respiratory Tract Infections (1)
Biological Products (1) · Fish Oils (1)
ALK-Abelló A/S (1) · Allergopharma GmbH & Co. KG (1) · HAL Allergy (1) · Johann Wolfgang Goethe University Hospital (1) · Stallergenes Greer (1)
France (2) · Germany (2) · Bulgaria (1) · Latvia (1) · Lithuania (1) · Poland (1) · United States (1)
Annemie Narkus, M.D. (1) · Hans Hoogeveen (1) · Pascal Demoly, MD (1) · Prof. Stefan Zielen, M.D. (1) · Tom Casale, MD (1)
PMID 20624650, PMID 29656145, PMID 38225952, PMID 39035788
2004 (1), 2023 (1)